⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9017923 | 1.00 | ALDH1A1 (0.36) | — | |
| SCHEMBL2687862 | 1.00 | ALDH1A1 (0.36) | — | |
| SCHEMBL2579894 | 0.88 | — | — | |
| SCHEMBL1961201 | 0.78 | ALDH1A1 (0.33) | — | |
| SCHEMBL28332622 | 0.78 | ALDH1A1 (0.33) | — | |
| SCHEMBL21814386 | 0.77 | ALDH1A1 (0.36) | — | |
| SCHEMBL11370229 | 0.75 | TSHR (0.40) | — | |
| SCHEMBL4434997 | 0.75 | TSHR (0.40) | — | |
| SCHEMBL16969621 | 0.75 | TSHR (0.40) | — | |
| SCHEMBL5505037 | 0.75 | TSHR (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0831770-B1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMA (US) | 2000-08-16 | — | — | EP | claimed |
| US-5874481-A | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-02-23 | — | — | US | claimed |
| EP-0831770-A1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | claimed |
| US-5667809-A | Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-09-16 | — | — | US | claimed |
| WO-1996040053-A1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040052-A1 | FLUOROCHEMICAL SOLUTIONS FOR THE DELIVERY OF LIPOPHILIC PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| US-9554993-B2 | Pulmonary delivery particles comprising an active agent | NOVARTIS AG (CH) | 2017-01-31 | — | — | US | disclosed |
| CN-105542104-A | Polyurethane hard foam thermal-insulation material | GUANGXI JISHUN ENERGY TECH CO LTD | 2016-05-04 | — | — | CN | disclosed |
| US-20140234223-A1 | NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS | GUERBET (FR) | 2014-08-21 | — | — | US | disclosed |
| US-8168223-B1 | Engineered particles and methods of use | NOVARTIS PHARMA AG (CH) | 2012-05-01 | — | — | US | disclosed |
| US-20100272823-A1 | PULMONARY DELIVERY PARTICLES COMPRISING WATER INSOLUBLE OR CRYSTALLINE ACTIVE AGENTS | NOVARTIS PHARMA AG (CH) | 2010-10-28 | — | — | US | disclosed |
| EP-1019022-B2 | METHOD FOR FORMING A POWDER COMPRISING PERFORATED MICROPARTICLES | NOVARTIS AG (CH) | 2010-07-28 | — | — | EP | disclosed |
| US-20080233194-A1 | Dispersion for pulmonary delivery of a bioactive agent | NEKTAR THERAPEUTICS (US) | 2008-09-25 | — | — | US | disclosed |
| EP-0831770-A1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5733526-A | DISPERSION OF EMULSIONS AND ADMINISTERING BIOACTIVE AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-03-31 | — | — | US | disclosed |
| WO-1998005301-A1 | MULTIPLE EMULSIONS COMPRISING A HYDROPHOBIC CONTINUOUS PHASE | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-02-12 | — | — | WO | disclosed |
| US-5667809-A | Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-09-16 | — | — | US | disclosed |
| WO-1997003644-A1 | REVERSE GELS COMPRISING A CONTINUOUS FLUORINATED PHASE | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-02-06 | — | — | WO | disclosed |
| WO-1996040053-A1 | CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040052-A1 | FLUOROCHEMICAL SOLUTIONS FOR THE DELIVERY OF LIPOPHILIC PHARMACEUTICAL AGENTS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |